Number of Citations*: 7
Latest Citations: For a complete list, please click here .
*Source: https://scholar.google.com/
Single-Cell Cloning Remains a Challenge
Regulatory agencies say that recombinant proteins intended for therapeutic must be produced from a cell line derived from a single progenitor cell. In addition, single-cell cloning has gained increasing importance as genome editing techniques has entered routine laboratory practice.
Single-Cell Printing for Establishing Monoclonality
The increasing adoption of large protein biologics such as monoclonal antibodies (mAbs) for the treatment of disease has heralded unprecedented growth in the R&D of novel therapeutics and biosimilar, bringing unique challenges to the biopharmaceuticals company.